Comparison of adherence and persistence among adults with type 2 diabetes mellitus initiating saxagliptin or linagliptin

References

• Centers for Disease Control [webpage on the Internet]Crude and Age-Adjusted Rates of Diagnosed Diabetes Per 100 Civilian, Non-Institutionalized Population, United States, 1980–20142015 Available from: www.cdc.gov/diabetes/statistics/prev/national/figage.htmAccessed December 3, 2015
   Google Scholar
• Centers for Disease Control [webpage on the Internet]National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 20142014 Available from: www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdfAccessed January 11, 2016
   Google Scholar
• American Diabetes Association [webpage on the Internet]Statistics About Diabetes: Overall Numbers, Diabetes, and Prediabetes2014 Available from: www.diabetes.org/diabetes-basics/statistics/Accessed December 3, 2015
   Google Scholar
• American Diabetes AssociationStandards of medical care in diabetes – 2014Diabetes Care201437suppl 1S14S8024357209
   PubMed Web of Science ®Google Scholar
• InzucchiSEBergenstalRMBuseJBManagement of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia20125561577159622526604
   PubMed Web of Science ®Google Scholar
• HandelsmanYBloomgardenZGrunbergerGAmerican Association of Clinical Endocrinologists and American College of Endocrinology – clinical practice guidelines for developing a diabetes mellitus comprehensive care plan – 2015Endocr Pract20152118725869408
   PubMed Web of Science ®Google Scholar
• AscheCLaFleurJConnerCA review of diabetes treatment adherence and the association with clinical and economic outcomesClin Ther2011337410921397776
   PubMed Web of Science ®Google Scholar
• DonnellyLAMorrisADEvansJMDARTS/MEMO CollaborationAdherence to insulin and its association with glycaemic control in patients with type 2 diabetesQJM200710034535017504861
   PubMed Web of Science ®Google Scholar
• HoPMRumsfeldJSMasoudiFAEffect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitusArch Intern Med20061661836184117000939
   PubMed Web of Science ®Google Scholar
• RozenfeldYHuntJSPlauschinatCWongKSOral antidiabetic medication adherence and glycemic control in managed careAm J Manag Care200814717518269302
   PubMed Web of Science ®Google Scholar
• BreitscheidelLStamenitisSDippelFWSchoffskiOEconomic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: a review paperJ Med Econ20101381519947905
   PubMedGoogle Scholar
• CurkendallSMThomasNBellKFJuneauPLWeissAJPredictors of medication adherence in patients with type 2 diabetes mellitusCurr Med Res Opin2013291275128623815104
   PubMed Web of Science ®Google Scholar
• RoebuckMCLibermanJNGemmill-ToyamaMBrennanTAMedication adherence leads to lower health care use and costs despite increased drug spendingHealth Aff (Millwood)201130919921209444
   PubMed Web of Science ®Google Scholar
• WhiteTJVanderplasAChangEDeziiCMAbramsGDThe costs of non-adherence to oral antihyperglycemic medication in individuals with diabetes mellitus and concomitant diabetes mellitus and cardiovascular disease in a managed care environmentDis Manage Health Outcomes200412181188
   Google Scholar
• JhaAKAubertREYaoJTeagardenJREpsteinRSGreater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annuallyHealth Aff (Millwood)2012311836184622869663
   PubMed Web of Science ®Google Scholar
• AstraZeneca [webpage on the Internet]Onglyza Prescribing Information2015 Available from: www.azpicentral.com/onglyza/pi_onglyza.pdf#page=1Accessed December 3, 2015
   Google Scholar
• Boehringer Ingelheim [webpage on the Internet]Tradjenta Prescribing Information2015 Available from: docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Tradjenta/Tradjenta.pdfAccessed December 3, 2015
   Google Scholar
• CraddyPPalinHJJohnsonKIComparative effectiveness of dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a systematic review and mixed treatment comparisonDiabetes Ther20145114124664619
   PubMed Web of Science ®Google Scholar
• MessoriAFaddaVMarateaDTrippoliSMarinaiCTesting the therapeutic equivalence of alogliptin, linagliptin, saxagliptin, sitagliptin, or vildagliptin as monotherapy or in combination with metformin in patients with type 2 diabetesDiabetes Ther20145134134424793219
   PubMed Web of Science ®Google Scholar
• EspositoKChiodiniPMaiorinoMIA nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24,163 patientsBMJ Open201552e005892
   PubMed Web of Science ®Google Scholar
• YangWCaiXHanXJiLDPP-4 inhibitors and risk of infections: a meta-analysis of randomized controlled trialsDiabetes Metab Res Rev201632439140426417956
   PubMed Web of Science ®Google Scholar
• NagelAKAhmed-SarwarNWernerPMCiprianoGCVan ManenRPBrownJEDipeptidyl peptidase-4 inhibitor-associated pancreatic carcinoma: a review of the FAERS databaseAnn Pharmacother2016501273126497885
   PubMed Web of Science ®Google Scholar
• FarrAMSheehanJJCurkendallSMSmithDMJohnstonSSKalsekarIRetrospective analysis of long-term adherence to and persistence with DPP-4 inhibitors in US adults with type 2 diabetes mellitusAdv Ther201431121287130525504156
   PubMed Web of Science ®Google Scholar
• RascatiKWorleyKMeahYEverhartDCharacteristics of and medication adherence for diabetic patients receiving dipeptidyl peptidase-4 inhibitors in US Medicare and commercial insurance planPresented at: the Academy of Managed Care Pharmacy NexusOctober 26–29, 2015Orlando, FL
   Google Scholar
• Truven Health Analytics [webpage on the Internet]MarketScan Bibliography2014 Available from: sites.truvenhealth.com/bibliography/2014TruvenHealthMarketScanBibliography.pdfAccessed December 3, 2015
   Google Scholar
• Centers for Medicare and Medicaid Services [webpage on the Internet]Part C and D Performance Data2015 Available from: www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/PerformanceData.htmlAccessed December 17, 2015
   Google Scholar
• DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol19924566136191607900
   PubMed Web of Science ®Google Scholar
• GibsonTBJingYKimECost-sharing effects on adherence and persistence for second-generation antipsychotics in commercially insured patientsManag Care2010198404720822071
   PubMedGoogle Scholar
• FarrAMSheehanJJohnstonSSKalsekarISimulation study of switching among diabetes medications associated with differential adherence: impact on prescription drug plan rankings for Medicare Star Ratings Measure D13-Medication Adherence for Diabetes MedicationsPresented at: AMCP 2014 NexusOctober 7–10, 2014Boston, MA
   Google Scholar